Industry Newsroom

Private Capital-Backed Chinese Drug Developer Akeso Biopharma Raises USD333m via IPO on HKEX

Private capital-backed Chinese biopharmaceutical company Akeso Biopharma has raised USD333m in an IPO on the Hong Kong Stock Exchange. Read more